American Shared Hospital Services (AMS)
XASE:AMS
Want to see AMS full AI Analyst Report?
AMS Stock Chart & Stats
$2.10
$0.00(0.00%)
At close: 4:00 PM EST
$2.10
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$1.25 - $3.11
Previous CloseN/A
Volume1.50K
Average Volume (3M)78.93K
Market Cap
$12.15M
Enterprise Value$30.70M
Total Cash (Recent Filing)$3.46M
Total Debt (Recent Filing)$22.61M
Price to Earnings (P/E)―
Beta0.25
Next Earnings
May 20, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.23
Shares Outstanding6,602,000
10 Day Avg. Volume41,017
30 Day Avg. Volume78,931
Financial Highlights & Ratios
PEG Ratio0.05
Price to Book (P/B)0.58
Price to Sales (P/S)0.50
P/FCF Ratio>-0.01
Enterprise Value/Market Cap2.53
Enterprise Value/Revenue1.09
Enterprise Value/Gross Profit6.06
Enterprise Value/Ebitda7.55
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Shift To Direct Patient CareA sustained shift toward direct patient care changes the revenue mix from lease-like to utilization-linked income. This produces more predictable, scalable cash flows as centers ramp, aligns incentives with treatment volume, and supports margin recovery if utilization and payer mix remain stable.
LINAC Volume And Revenue ExpansionRapid LINAC volume growth leverages largely fixed clinical and equipment costs, improving unit economics as centers mature. Durable session growth demonstrates market demand and asset utilization, which can sustainably lift gross margins and cash generation as new centers reach steady-state throughput.
Long-term Partnership And Lease CertaintyA multi-year lease extension with Orlando Health secures a long-duration revenue stream and reduces disposition risk for a capital-intensive asset. Contract clarity on purchase options, maintenance and insurance supports planning, preserves clinical continuity, and underpins durable revenue from proton therapy.
Bears Say
Gross Margin Compression & Profitability DeclineSharp, sustained margin compression materially reduces the cushion to cover fixed costs and service capital-intensive equipment. Lower gross margins undermine adjusted EBITDA and free cash flow, indicating structural pricing/reimbursement or cost pressures that must be reversed to restore long-term financial health.
Persistent Negative Free Cash FlowConsecutive years of negative free cash flow constrain the company's ability to self-fund growth and maintenance capex for complex clinical assets. Sustained negative FCF forces dependence on external financing, increases refinancing risk, and limits operational flexibility until consistent positive cash generation is restored.
Debt, Covenant Pressure And Going-Concern RiskMaterial debt levels combined with covenant breaches create acute refinancing and negotiation risk. Lender amendments are required to avoid remedies; until resolved this impairs strategic options, may increase borrowing costs or force asset sales, and represents a persistent near-term threat to continuity.
American Shared Hospital Services News
AMS FAQ
What was American Shared Hospital Services’s price range in the past 12 months?
American Shared Hospital Services lowest stock price was $1.25 and its highest was $3.11 in the past 12 months.
What is American Shared Hospital Services’s market cap?
American Shared Hospital Services’s market cap is $12.15M.
When is American Shared Hospital Services’s upcoming earnings report date?
American Shared Hospital Services’s upcoming earnings report date is May 20, 2026 which is in 14 days.
How were American Shared Hospital Services’s earnings last quarter?
American Shared Hospital Services released its earnings results on Mar 31, 2026. The company reported -$0.09 earnings per share for the quarter, missing the consensus estimate of -$0.01 by -$0.08.
Is American Shared Hospital Services overvalued?
According to Wall Street analysts American Shared Hospital Services’s price is currently Overvalued.
Does American Shared Hospital Services pay dividends?
American Shared Hospital Services does not currently pay dividends.
What is American Shared Hospital Services’s EPS estimate?
American Shared Hospital Services’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does American Shared Hospital Services have?
American Shared Hospital Services has 6,602,000 shares outstanding.
What happened to American Shared Hospital Services’s price movement after its last earnings report?
American Shared Hospital Services reported an EPS of -$0.09 in its last earnings report, missing expectations of -$0.01. Following the earnings report the stock price went down -19.89%.
Which hedge fund is a major shareholder of American Shared Hospital Services?
Currently, no hedge funds are holding shares in AMS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
American Shared Hospital Services
American Shared Hospital Services (AMS) is a leading provider of advanced medical equipment and services to healthcare facilities across the United States. The company specializes in offering cutting-edge technologies in the field of radiation therapy, particularly in the areas of stereotactic radiosurgery and stereotactic body radiation therapy. AMS partners with hospitals and healthcare organizations to enhance their treatment capabilities, thereby improving patient outcomes and operational efficiencies. The core services include the leasing of medical equipment, providing maintenance and support, and offering training for healthcare personnel.
AMS Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call described meaningful operational progress—growth in direct patient care, strong LINAC volume expansion, international gains, partnership extensions and stabilized clinical staffing—positioning the company for future growth. However, these positives are counterbalanced by significant near-term financial stress: compressed gross margins, a full-year net loss versus prior-year income, a large decline in cash balance, unmet covenant metrics, and a stated going-concern risk that requires lender amendments. Management is optimistic about the long-term trajectory, but the company's liquidity and covenant issues represent material short-term risks.View all AMS earnings summariesTechnical Analysis
Ownership Overview
25.65% Insiders
6.72% Mutual Funds
0.45% Other Institutional Investors
64.52% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---